Evidence map›Paper›PMID 36229849›Full record

ArticleRadiation oncology (London, England)2022

Evaluation of a hybrid automatic planning solution for rectal cancer.

Jiyou Peng, Lei Yu, Fan Xia, Kang Zhang, Zhen Zhang, Jiazhou Wang, Weigang Hu

Abstract read
In one paragraph

Article in Radiation oncology (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiyou PengDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Lei YuDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Fan XiaDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Kang ZhangUnited Imaging Healthcare, Shanghai, China.
Zhen ZhangDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Jiazhou WangDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. wjiazhou@gmail.com.
Weigang HuDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. jackhuwg@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundScript-based planning and knowledge-based planning are two kinds of automatic planning solutions. Hybrid automatic planning may integrate the advantages of both solutions and provide a more robust automatic planning solution in the clinic. In this study, we evaluated and compared a commercially available hybrid planning solution with manual planning and script-based planning.

methodsIn total, 51 rectal cancer patients in our institution were enrolled in this study. Each patient generated 7 plans: one clinically accepted manual plan ([Formula: see text]), three script-based plans and three hybrid plans generated with the volumetric-modulated arc therapy technique and 3 different clinical goal settings: easy, moderate and hard ([Formula: see text], [Formula: see text], [Formula: see text], [Formula: see text], [Formula: see text] and [Formula: see text]). Planning goals included planning target volume (PTV) D

resultsCompared to manual planning, hybrid planning with all settings significantly reduced the OAR dose (p < 0.05, paired t-test or Wilcoxon signed rank test) for all dose-volume indices, except D

conclusionsThe hybrid planning solution was manual-planning comparable for rectal cancer. Hybrid planning can provide a better and more robust plan quality than script-based planning.

Indexed as

Radiotherapy, Intensity-ModulatedRectal NeoplasmsHumansKnowledge BasesOrgans at RiskRadiotherapy DosageRadiotherapy Planning, Computer-AssistedAutomatic planningHybrid planningKnowledge-based planningRectal cancerScript-based planning

Identifiers

PMID36229849
PMCPMC9563136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.